{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = [(8''R'',9''S'',13''S'',14''S'',17''S'')-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[''a'']phenanthren-3-yl] acetate
| image = Estradiol 3-acetate.svg
| width = 250px

<!--Clinical data-->
| pronounce = {{IPAc-en|ˌ|ɛ|s|t|r|ə|ˈ|d|aɪ|oʊ|l|_|ˈ|æ|s|ə|t|eɪ|t}} {{respell|ES|trə|DYE|ohl|_|ASS|ə|tayt}}<ref name="Drugs.com-2">https://www.drugs.com/cdi/estradiol-acetate.html</ref>
| tradename = Femtrace, Femring, Menoring
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = Rx-only
| routes_of_administration = [[Oral administration|By mouth]], [[Intravaginal administration|vaginal]] ([[vaginal ring|ring]])

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 

<!-- Identifiers -->
| CAS_number_Ref = 
| CAS_number = 4245-41-4
| CAS_supplemental = 
| ATC_prefix = G03
| ATC_suffix = CA03
| ATC_supplemental = 
| PubChem = 9818306
| IUPHAR_ligand = 
| DrugBank_Ref = 
| DrugBank = DBSALT000065
| ChemSpiderID_Ref = 
| ChemSpiderID = 7994056
| UNII = 5R97F5H93P
| KEGG = D04061
| ChEBI = 
| ChEMBL = 1200430
| synonyms = E2A; E3A; Estradiol 3-acetate

<!--Chemical data-->
| C=20 | H=26 | O=3
| molecular_weight = 314.419 g/mol
| SMILES = C(C)(=O)Oc1ccc2[C@@H]3CC[C@@]4([C@H](CC[C@@H]4[C@@H]3CCc2c1)O)C
| StdInChI_Ref = 
| StdInChI = 1S/C20H26O3/c1-12(21)23-14-4-6-15-13(11-14)3-5-17-16(15)9-10-20(2)18(17)7-8-19(20)22/h4,6,11,16-19,22H,3,5,7-10H2,1-2H3/t16-,17-,18+,19+,20+/m1/s1
| StdInChIKey_Ref = 
| StdInChIKey = FHXBMXJMKMWVRG-SLHNCBLASA-N
}}

'''Estradiol acetate''', sold under the brand names '''Femtrace''', '''Femring''', and '''Menoring''', is an [[estrogen]] which is used in the [[United States]], [[Europe]], and elsewhere throughout the world.<ref name="Drugs.com">https://www.drugs.com/international/estradiol-acetate.html</ref><ref name="pmid12892687">{{cite journal | vauthors = Buckler H, Al-Azzawi F | title = The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women | journal = BJOG | volume = 110 | issue = 8 | pages = 753–9 | year = 2003 | pmid = 12892687 | doi = 10.1016/s1470-0328(03)02908-2| url = }}</ref> It is a [[synthetic compound|synthetic]] [[estrogen ester]] which acts as a [[prodrug]] of [[estradiol]], and hence is considered to be a [[natural product|natural]] and [[bioidentical hormone replacement therapy|bioidentical]] form of estrogen.<ref name="OettelSchillinger2012">{{cite book|author1=Michael Oettel|author2=Ekkehard Schillinger|title=Estrogens and Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogen|url=https://books.google.com/books?id=wBvyCAAAQBAJ&pg=PA261|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-3-642-60107-1|pages=261–}}</ref>

{{TOC limit|3}}

==Medical uses==
{{Main article|Estradiol (medication)#Medical uses}}

Estradiol acetate is used as a component of [[hormone replacement therapy]] to treat and prevent symptoms of [[menopause]] such as [[osteoporosis]] in [[postmenopausal]] women.<ref name="pmid14551014" /><ref name="pmid15879923">{{cite journal |vauthors=Al-Azzawi F, Lees B, Thompson J, Stevenson JC | title = Bone mineral density in postmenopausal women treated with a vaginal ring delivering systemic doses of estradiol acetate | journal = Menopause (New York, N.Y.) | volume = 12 | issue = 3 | pages = 331–9 | year = 2005 | pmid = 15879923 | doi = 10.1097/01.gme.0000163870.03388.4d| url = http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=1072-3714&volume=12&issue=3&spage=331}}</ref><ref name="pmid16278614">{{cite journal |vauthors=Utian WH, Speroff L, Ellman H, Dart C | title = Comparative controlled trial of a novel oral estrogen therapy, estradiol acetate, for relief of menopause symptoms | journal = Menopause (New York, N.Y.) | volume = 12 | issue = 6 | pages = 708–15 | year = 2005 | pmid = 16278614 | doi = 10.1097/01.gme.0000184220.63459.a8 | url = http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=1072-3714&volume=12&issue=6&spage=708}}</ref><ref name="pmid16735941">{{cite journal |vauthors=Speroff L, Haney AF, Gilbert RD, Ellman H | title = Efficacy of a new, oral estradiol acetate formulation for relief of menopause symptoms | journal = Menopause (New York, N.Y.) | volume = 13 | issue = 3 | pages = 442–50 | year = 2006 | pmid = 16735941 | doi = 10.1097/01.gme.0000182802.06762.b2 | url = http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=1072-3714&volume=13&issue=3&spage=442}}</ref>

The [[Women's Health Initiative]] studies report increased health risks for postmenopausal women when using unopposed estrogens.<ref name="FemringLabel">{{cite web|title=FEMRING|url=http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=86b90d68-bfb6-47f6-aa5b-a6642391ff13#i4i_clinical_studies_id_2a230567-d4b8-4161-9dd0-fb082cd301e5|website=DailyMed|publisher=U.S. National Library of Medicine|accessdate=June 2010}}</ref> Estrogens with or without progestins should be prescribed at the lowest effective doses and for the shortest duration consistent with treatment goals and risks for the individual woman.<ref name="FemringLabel" />

==Side effects==
{{Main article|Estradiol (medication)#Adverse effects}}

The [[side effect]]s of estradiol acetate are the same as those of estradiol. Examples of such side effects include [[breast tenderness]] and [[breast enlargement|enlargement]], [[nausea]], [[bloating]], [[edema]], [[headache]], and [[melasma]].<ref name="Ghosh2010">{{cite book|author=Amit K. Ghosh|title=Mayo Clinic Internal Medicine Board Review|url=https://books.google.com/books?id=LS65jBzoD40C&pg=PA222|date=23 September 2010|publisher=OUP USA|isbn=978-0-19-975569-1|pages=222–}}</ref>

==Chemistry==
{{See also|Estrogen ester}}

Estradiol acetate is a [[synthetic compound|synthetic]] [[estrane]] (C18) [[steroid]] and the C3 [[acetic acid|acetate]] [[fatty acid]] [[ester]] of [[estradiol]].<ref name="Drugs.com" /> It is also known as '''estra-1,3,5(10)-triene-3,17β-diol 3-acetate'''.<ref name="Drugs.com" /> Another common ester of estradiol in use is [[estradiol valerate]], which is a C17β ester of estradiol.

==History==
Estradiol acetate is relatively recent to the market, having been first approved in a [[vaginal ring]] [[drug formulation|formulation]] as Menoring in the [[United Kingdom]] in 2001,<ref name="pmid14551014">{{cite journal | author = Speroff L | title = Efficacy and tolerability of a novel estradiol vaginal ring for relief of menopausal symptoms | journal = Obstetrics and Gynecology | volume = 102 | issue = 4 | pages = 823–34 |date=October 2003 | pmid = 14551014 | doi = 10.1016/s0029-7844(03)00764-6| url = }}</ref> followed by another vaginal ring formulation as Femring in the [[United States]] in 2003,<ref name="pmid17506242">{{cite journal |vauthors=Sivanandy MS, Masimasi N, Thacker HL | title = Newer hormonal therapies: lower doses; oral, transdermal, and vaginal formulations | journal = Cleveland Clinic Journal of Medicine | volume = 74 | issue = 5 | pages = 369–75 |date=May 2007 | pmid = 17506242 | doi = 10.3949/ccjm.74.5.369| url = http://www.ccjm.org/cgi/pmidlookup?view=long&pmid=17506242}}</ref> and finally as an [[oral administration|oral]] preparation as Femtrace in the United States in 2004.<ref name="pmid17506242" />

==Society and culture==

===Generic name===
''Estradiol acetate'' is the [[generic term|generic name]] of the drug and its {{abbrlink|USAN|United States Adopted Name}}.<ref name="Drugs.com" />

==See also==
* [[List of estrogen esters]]

==References==
{{Reflist|30em}}


{{Estrogens and antiestrogens}}
{{Estrogen receptor modulators}}

[[Category:Acetate esters]]
[[Category:Alcohols]]
[[Category:Estradiol esters]]
[[Category:Estranes]]
[[Category:Prodrugs]]
[[Category:Synthetic estrogens]]